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ADMITTED TO A PAEDIATRIC 
INTENSIVE CARE UNIT 
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Objective. To determine the aetiological agents and outcome 
of severe community-acquired pneumonia (SCAP) in 
children admitted to the paediatric intensive care unit 
(PICU) at Kalafong Hospital, Pretoria. 
Patients and methods. An audit was done after a protocol was 
implemented to identify the aetiological agents in children 
with life-threatening SCAP admitted to the PICU from the 
emergency room. The following investigations were done as 
per protocol: blood culture, culture of the tracheal aspirate, 
immunofluorescence and culture of the nasopharyngeal 
aspirate, microscopy and culture of the gastric juice for 
Mycobacterium tuberculosis, and determination of HIV status. 
The following data, documented prospectively, were 
obtained from patient records: date of admission, age, 
gender, weight, duration of ventilation, duration of stay in 
the PICU, survival or death, and severity of illness as 
determined by means of the score for acute neonatal 
physiology (SNAP) or paediatric risk of mortality (PRISM) 
score depending on the child's age. 
Results. Twenty-three children were admitted over a 1-year 
period (1 November 1994-30 October 1995). Their median 
age was 10 weeks (range 2 weeks- 5 years) and the sex 
distribution was equal. 
Two children were HIV-infected. Twenty children 
received mechanical ventilation for a median period of 6.5 
days (range 2- 16 days). Aetiological agents were identified 
in 15/23 children (65%). 
Respiratory syncytial virus (RSV) was the most common 
pathogen, identified in 7/23 children. Klebsiella pneumoniae 
was the most common bacterial pathogen, identified in 5 
children (2 blood cultures and 3 tracheal aspirates). 
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Tuberculosis was not diagnosed. The mean PRISM score was 
similar in survivors and children who died. The case fatality 
rate was 30%. The 7 children who died had a median arterial 
oxygen tension/ fraction of inspired oxygen (Pa02/FiO,) ratio 
of 94 (range 32- 111) and the 16 survivors had a median ratio 
of 146 (range 51 - 252) (P = 0.01) on admission. Both HIV-
infected children died and postmortem examination showed 
a pneumonia due to Pneumocystis carinii and 
cytomegalovirus. 
Conclusions. SCAP occurs in very young children. One or 
morepathogens were isolated in 65% of cases. Viral 
pathogens predominated, with RSV being the most common. 
The yield of positive blood cultures was low at 17%. 
Streptococcus pneumoniae and Haemophilus influenzae were not 
found. The case fatality rate was 30% and death was more 
likely with a low PaO,/FiO, ratio on admission. 
5 Afr Med / 2002; 92: 907-911. 
Pneumonia is the major cause of death in childhood, 
accounting for approximately 5 million deaths per year in 
children younger than 5 years, mainly in developing countries,'' 
and surpassing diarrhoea as a cause of death.5 Since the 
majority of developing countries do not have paediatric 
intensive care units (PICUs) to manage children with severe 
community-acquired pneumonia (SCAP) at risk of dying, a 
paucity of published data is available addressing the issues of 
the aetiology and outcome of these children when admitted to 
an intensive care unit (ICU).3•6 Published data from developed 
countries are also not available because apart from children 
with bronchiolitis, SCAP is an extremely rare cause of 
admission to ICUs in these countries. 
Identification of the most common bacterial pathogens in 
children with SCAP is important to aid in the decision 
regarding empirical antibiotics. However, it is difficult to 
identify bacterial pathogens in childhood pneumonia. 
Distinctive clinical and radiographic appearances are not 
indicative of specific pathogens in the majority of children.'·' 
Even though the most likely aetiological agent can be deduced 
from the age of the child, i.e. bacteria predominating in 
neonates and viruses in older children up to 5 years, with 
bacteria again predominating in children older than 5 years,'·9 
these findings vary depending on geographical location, time 
of year, and the diagnostic methodology employed.10 This is 
illustrated by the fact that in poor communities the prevalence lmiJ 
of bacterial pneumonia is higher than that of viral pneumonia 
in all age groupsY·12 Blood cultures are most commonly used to 
identify bacterial pathogens, but the yield is notoriously low at 
10- 20%.'·'·' Lung aspirates are more sensitive than blood 
cultures and because they do not require sophisticated 
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technology, have been used in developing countries to identify 
bacterial pathogens.U-13 This method remains the gold standard 
for the identification of bacterial pathogens, but is seldom 
justified in cases of childhood pneumonia.14 Antibody assays 
are insensitive in the aetiological diagnosis of bacterial 
pneumonia, particularly in children younger than 2 years of 
age because they respond poorly to polysaccharide antigens. 14 
An additional diagnostic modality is antigen detection. 
However, this method is expensive and available only in 
sophisticated laboratories. It has been used in research studies 
which showed that Streptococcus pneumoniae and Haemophilus 
influenzae are the most common bacterial pathogens in the 
causation of childhood pneumonia in developed14 and 
developing countries.15 However, non-typeable 
H. influenzae remains unidentified by means of this method and 
its role in the causation of childhood pneumonia is probably 
underestimated.1' Culture of induced sputum is an alternative 
to determine the bacterial aetiology of pneumonia.16 
Guidelines regarding empirical antibiotic therapy in 
community-acquired pneumonia cover the most common 
bacterial pathogens in the different age groups,'·9 •10 but it is not 
known whether these guidelines can be extrapolated to 
children with SCAP in intensive care settings in developing 
countries. Although data from adult ICUs show that early 
empirical therapy directed at likely pathogens is more likely to 
improve outcome than the identification of the pathogen per 
se/7 this evidence is not available for children. 
Respiratory viruses are important pathogens in childhood 
pneumonia. These can be identified rapidly and with relative 
ease by immunofluorescence on nasopharyngeal aspirates/' 
provided that a virology service is available. However, viral 
and bacterial pathogens may occur concurrently, with a virus 
infection having set the stage for a secondary bacterial 
infection. 14•18 
A protocol was implemented to determine the aetiological 
agents of SCAP in children with respiratory failure admitted to 
the PICU at Kalafong Hospital in Pretoria. This study reports 
on an audit of the aetiological agents identified over a 1-year 
period after the protocol was initiated, and the short-term 
outcome of the children for this period. 
pATIENTS AND METHODS 
The 6-bed PICU at Kalafong Hospital is one of two referral 
centres in the Pretoria region for critically ill children between 
0 and 12 years from poor communities. Children are referred 
from hospitals within a radius of approximately 200 km of 
Kalafong Hospital. The number of children admitted annually 
averages 330- 350, of whom approximately 20% are non-
neonates. The unit is labelled a PICU I neonatal intensive care 
unit (NICU) and will hereafter be referred to as the PICU. 
The protocol was applied to children with SCAP admitted 
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directly to the PICU from the emergency room. Direct 
admission to the PICU was indicated if intubation was carried 
out in the emergency room as a life-saving procedure or if the 
respiratory rate of a child exceeded 80 - 90 breaths per minute, 
with apnoea anticipated as a result of exhaustion. Radiological 
findings after admission to the PICU had to be compatible with 
pneumonia for definite enrolment into the study. After 
stabilising the child in the PICU the following investigations as 
per protocol were carried out to determine the aetiological 
agents: a blood culture using the BACTEC 9240 continuous 
monitored system, a tracheal aspirate for culture of bacterial 
and viral pathogens, a nasopharyngeal aspirate for 
immunofluorescence, followed by culture to identify 
respiratory viruses (respiratory syncytial virus (RSV), 
adenovirus, influenza, para-influenza, measles and 
cytomegalovirus (CMV)). Gastric juice was examined by means 
of rhodamine-auramine fluorochromic staining, followed by 
culture for Mycobacterium tuberculosis. All mothers were 
counselled regarding HIV testing of their children. If 
permission was obtained, screening was performed after 
admission to the PICU for HIV seropositivity using an enzyme-
linked immunosorbent assay (ELISA) test. A positive test was 
confirmed by a second ELISA test, followed by a DNA-PCR 
test. All mothers received post-test counselling and HIV-
infected children were included in the audit. 
Severity of illness was determined after a stay of at least 8 
hours in the PICU as is the standard procedure. The score for 
acute neonatal physiology (SNAP)19 was used for children 
younger than 1 month, and the paediatric risk of mortality 
(PRISM) score20 for children 1 month and older. The arterial 
oxygen tension/fraction of inspired oxygen (PaO,/FiO,) ratio 
was determined using the PaO, obtained on the first blood gas 
analysis after admission to the PICU and thereafter as a 
parameter of the SNAP or PRISM score. The duration of 
mechanical ventilation and stay in the PICU were documented. 
The outcome was determined as survival until discharge from 
the PICU. 
RESULTS 
Twenty-three children were admitted over a 1-year period 
(1 November 1994-31 October 1995). Their median age was 10 
weeks (range 2 weeks - 5 years) and the sex distribution was 
equal. Six of these children were ex-prematures. Their median 
chronological age was 5.5 weeks (range 3 - 12 weeks) and their 
median weight on admission was 2.3 kg (range 1.9-3 kg). All 
children received HIV testing and 2/23 were infected. 
The mean SNAP for children younger than 1 month (N = 5) 
was 15. One of these children, with a SNAP of 27, subsequently 
died. The mean PRISM score for the children older than 1 
month (N = 17) was 11.8. 
Twenty children received mechanical ventilation for a 
median period of 6.5 days (range 2- 16 days). The median 
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period of ventilation for the 13 children who survived was 5 
days (range 2- 11 days) compared with 9 days (range 4- 16 
days) for the 7 children who died. The PaO,/FiO, ratio was 
determined in 21 children on admission and ranged between 
32 and 252, with a median value of 111. The median was 146 
(range 51 - 252) for the survivors. The mean PaO,/FiO, of the 7 
children who died was 94 (range 32- 111) (P = 0.0054). The 
median length of stay in the PICU for the group as a whole 
was 6 days (range 2- 19 days). The median length of stay for 
the children who survived was 5.5 days (range 2- 14 days), 
and 9 days (range 4- 19 days) for the children who died. 
Aetiological agents were identified in 15/23 children (65%). 
RSV was the most common pathogen (7 /15) -the single 
pathogen in 4 children and in combination with a viral or 
bacterial pathogen in 3 children. A CMV was identified in 2 
patients as a single pathogen, and in combination with 
bacterial pathogens in 1 child. Klebsiella pneumoniae was the 
most common bacterial pathogen, identified in 5 children, 2 of 
whom had positive blood cultures. In 1 child serological 
investigation for adenovirus showed the presence of 
immunoglobulin G (IgG) and immunoglobulin M (IgM) 
antibodies suggestive of an adenovirus infection. No other 
pathogen was identified in this child. Four of 23 children (17%) 
had positive blood cultures on admission. Three of the 4 
children with positive blood cultures died, including the 2 HIV-
infected children. The clinical features of the 7 children with 
RSV pneumonia are given in Table I. All these children were 
admitted from April to August 1995. Three children were ex-
prematures. One of the 7 children died. The characteristics of 
the children with RSV pneumonia were compared with those 
of the rest of the study group (Table II). The median age of the 
children with RSV pneumonia was 4 weeks (range 3 - 12 
weeks), while the median age of children in whom no RSV was 
identified was 11 weeks (range 2- 240 weeks) (P = 0.05). The 
median PaO,/FiO, ratio and mortality did not differ between 
the two groups. 
Tuberculosis was not identified in any of the children. 
Table I. Characteristics of children with RSV pneumonia 
Month of Age 
Table II. Characteristics of children with RSV pneumonia 
compared with the rest of the study group 
RSV Non-RSV 
(N= 7) (N = 16) P-value 
Age (weeks) 4 11 0.050 
(median, range) (3- 12) (2- 240) 
Ventilation (days) 6 7 (N = 13) NS 
(median, range) (2- 10) (2- 16) 
Length of stay (days) 7 6 NS 
(median, range) (4- 13) (2- 19) 
Prematures 3 3 NS 
PaO,/FiO, 125.5 111.0 NS 
(median, range) (51 - 250) (32- 252) 
Mortality(%) 14 37.5 NS 
NS ~ not significant. 
Seven of the 23 children died during their stay in the unit, 
with a case fatality rate of 30.4%. Twenty children were 
ventilated, of whom 3 had severe co-morbidity (two HIV-
infected, 1 pulmonary agenesis). Of the remaining 17 children, 
13 survived, probably because of the availability of an intensive 
care facility. 
The children who died were compared with those who 
survived with regard to age, PRISM score, SNAP, PaO,/FiO, 
ratio, HIV status and prematurity (Table III). The median age 
was not significantly different in the children who died 
compared with the survivors. Severity of illness as determined 
by the PRISM score was similar in the two groups. Death was 
more likely in children with a median PaO,/FiO, ratio of 94 or 
less on admission (P = 0.01). The 2 children who were HIV-
infected had positive blood cultures, and both died. 
Consent for a postmortem examination was obtained for 5 of 
the 7 children who died, including the 2 HIV-infected children. 
The predominant pathology in all the children was in the 
Mechanical 
ventilation Stay in 
admission (weeks) Prematuiity Pa02/Fi02 (days) PICU (days) Outcome 
April 3 No 100 7 13 Alive 
April 4 No Unknown 6 7 Alive 
April 12 Yes 109 4 4 Dead 
May 3 No 51 10 11 Alive 
May 5 No 250 2 4 Alive 
May 10 Yes 150 4 6 Alive 
August 3 Yes 142 7 12 Alive 
1m 
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Table III. Characteristics of survivors and children who died 
Survivors Deaths 
(N = 16) (N = 7) P-value 
Age (median, range) 5 weeks 15 weeks NS 
(2 -180) (3- 240) 
PRISM <mean, range) 11.27 (N =.11) 12.83 (N = 6) 
(1 - 22) (8- 22) 
SNAP (mean, range) 12 (N = 4) 27(N"'1) 
(11 - 13) 
PaO,/FiO, (median, 
range) 146 (N = 14) 94 0.01 
(51 - 252) (32- 111) 
HIV-infected children 0 2 
Prematures (N = 6) 5 1 
NS " not significant. 
lungs. Two of the 3 HIV-negative children had a viral 
pneumonia complicated by a bacterial pneumonia. The child 
with unilateral pulmonary agenesis had a severe bacterial 
haemorrhagic pneumonia. Both HIV-infected children had 
pneumonia due to Pneumocystis carinii as well as a CMV 
infection. 
DISCUSSION 
During the 1-year period of this audit SCAP was the reason for 
admission in at least 30% of children older than 28 days 
admitted to the unit. All these children had severe pneumonia, 
the complications of which were life-threatening at the time of 
admission to the emergency room. The median age was 10 
weeks, suggesting that young children are prone to SCAP, with 
6/23 born prematurely. 
The severity of illness of the 17 children older than 1 month, 
as determined by the PRISM score, was similar for the children 
who died and survivors. PRISM scores in the low ranges in 
disadvantaged children may not be a true reflection of severity 
of illness since they have a higher mortality than predicted.21 
The reason for this finding is not clear.21 One of the 7 children 
younger than 1 month who died had a SNAP of 27, while the 
mean SNAP of the survivors was 12. Data from the PICU at 
Kalafong Hospital showed that children with a SNAP higher 
than 20 have a greater risk of dying (S D Delport-
unpublished data). The median PaO,/FiO, ratio on admission 
was 94 in the 7 children who died and is significantly lower 
I'IDJ (P = 0.01) than the median value of 146 for the 14 survivors. 
Severe hypoxaemia on admission to the PICU may therefore be 
a grave prognostic indicator for survival. This finding has been 
described by others in a similar population.' 
Viruses were identified in 11/23 children- in isolation 
(6/11), in combination with another virus (2/11), or in 
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combination with bacteria (3/11). The child with the adenoviral 
pneumonia also had a bacterial pneumonia which was 
subsequently diagnosed on postmortem examination. RSV was 
the most common viral pathogen (7 /11). It occurred either in 
isolation (4/11) or in combination with another viral or 
bacterial pathogen (3/11). RSV pneumonia occurred only in 
autumn and winter. Young children and ex-prematures had 
RSV pneumonia, which is an expected finding. 22•23 The mortality 
rate of these infants was 14%, lower than the mortality rate of 
30% for the group as a whole. The duration of ventilation 
(median 6 days, range 2 - 10 days) and length of stay (median 7 
days, range 4- 13 days) were similar to those for the rest of the 
study group. 
A bacterial pathogen cultured from blood was found in only 
4/23 children (17%); 2 of these were from the HIV-infected 
children. This low yield of growth on blood cultures is in 
keeping with findings of other studies.'·'·' K. pneumoniae was the 
most common bacterial pathogen isolated (5/23)- from blood 
on 2 occasions and from a tracheal aspirate on 3 occasions. A 
similar study to ours from a developing country but carried 
out in an adult ICU reports K. pneumoniae to be the second 
most common bacterial pathogen." The bacterial pathogens 
traditionally regarded as being the most important in the 
causation of childhood pneumonia- 5. pneumoniae and H. 
influenzae- were not isolated during the time period of the 
audit. Possible reasons are the insensitivity of blood cultures in 
detecting bacteria, and exposure to antibiotics before 
admission. The latter possibility could not be excluded with 
certainty in our study since a history is unreliable. Prior 
exposure to antibiotics can only be excluded by testing the 
serum for antibiotic activity." 
Severe hypoxaemia after admission, as reflected by a low 
Pa02/Fi0, ratio, may be a predictor of a grave outcome in 
terms of survival. 
Bacterial pathogens are rarely isolated from blood cultures. 
5. pneumoniae and H. influenzae are not identified in children 
with SCAP. Possible reasons are that the diagnostic methods 
available at the local laboratory are not sensitive enough or that 
SCAP in children from developing countries is caused by 
bacteria other than 5. pneumoniae and H. influenzae, such as 
Gram-negative bacilli. 16 RSV is the most common pathogen 
identified in children with SCAP. 
Our findings relating to bacterial pathogens do not clarify 
the issues regarding empirical antibiotic therapy on admission. 
This highlights the need for prospective studies to identify the 
bacterial pathogens in children with SCAP admitted to ICUs in 
developing countries. Sputum induction in unintubated 
children and blind bronchoalveolar lavage (BAL) in intubated 
children are useful techniques26 to identify bacterial pathogens. 
Blind BAL compares well with bronchoscopic BAL'7 and open-
lung biopsy/8 and this method should replace tracheal 
aspirates. 
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EFFECT OF 1% AND 2% PROPOFOL 
ON BLOOD LIPIDS DURING LONG-
TERM SEDATION 
Andre Coetzee, Edward M Blaine, D Labadarios, 
Robert Schall, Matthias Haus 
Objectives. To compare the effects of 1% and 2% propofol on 
the maximum and average lipid levels, the relative frequency 
of hyperlipidaemia, the propofol dose required to achieve an 
equivalent degree of sedation, the pharmacodynamic effects 
at the required infusion rates, and the effect on respiratory 
function. 
Design. Open, randomised, parallel group, multicentre 
comparison study. 
Setting. Intensive care units (ICUs) at the Faculty of Medicine, 
University of Stellenbosch and at Vergelegen Medicity, 
Somerset West. 
Subjects. Patients who were artificially ventilated for at least 
72 hours in the ICUs and who required sedation or analgesia.. 
Outcome measures. Continuous intravenous infusion of 1% or 
2% propofol to provide an administration rate in the range of 
1 - 4 mg/kg/h. The initial infusion rate was about 2 
mg/kg/h, adjusted to achieve the appropriate level of 
sedation. 
Results and conclusions. Seventy-five patients were enrolled in 
the study, of which 72 were evaluable for safety analysis and 
58 were evaluable for efficacy analysis. The total daily dose 
of propofol (ml/ day) in the 2% propofol group was about 
60% of that in the 1% propofol group, indicating that the 
lipid load in the 2% propofol group had only slightly more 
than half the lipid load in the 1% propofol group. Thirteen of 
27 patients (48%) in the 2% propofol group had abnormally 
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